Pro Feature
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moWhy This Matters for Your Career
ANI Pharmaceuticals is hiring 1 role related to this product
NITAZOXANIDE (nitazoxanide) by ANI Pharmaceuticals is [ see microbiology (12. Approved for diarrhea caused by giardia lamblia, cryptosporidium parvum, cryptosporidium parvum (1). First approved in 2025.
Drug data last refreshed 21h ago
[ see Microbiology (12.4) ].
Antiprotozoal
Worked on NITAZOXANIDE at ANI Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Nitazoxanide for Treatment of Cryptosporidium in Children
Pharmacokinetic Study on G1090N (Nitazoxanide) Capsules in Healthy Volunteers
Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation
Nitazoxanide Pharmacokinetic Parameters in Renal Impaired Subjects
Nitazoxanide Pharmacokinetic Parameters in Hepatic Impaired Patients
Upgrade to Pro to access Medicare Part D spending data and other premium pharma intelligence.
Upgrade to Pro — $25/moANI Pharmaceuticals is hiring 1 role related to this product